GSK2838232
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for GSK2838232, covering 2017-01-18 to 2019-05-29. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults [Phase 2]